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Abstract
Background: Residential care facilities (RCFs) act as reservoirs for multidrug-resistant organisms (MDRO). There are
scarce data on colonisation with MDROs in Africa. We aimed to determine the prevalence of MDROs and C. difficile
and risk factors for carriage amongst residents of RCFs in Cape Town, South Africa.
Methods: We performed a cross-sectional surveillance study at three RCFs. Chromogenic agar was used to screen
skin swabs for methicillin-resistant S. aureus (MRSA) and stool samples for extended-spectrum beta-lactamase-
producing Enterobacteriaceae (ESBL-E). Antigen testing and PCR was used to detect Clostridiodes difficile. Risk factors
for colonisation were determined with logistic regression.
Results: One hundred fifty-four residents were enrolled, providing 119 stool samples and 152 sets of skin swabs.
Twenty-seven (22.7%) stool samples were positive for ESBL-E, and 13 (8.6%) residents had at least one skin swab
positive for MRSA. Two (1.6%) stool samples tested positive for C. difficile. Poor functional status (OR 1.3 (95% CI,
1.0–1.6)) and incontinence (OR 2.9 (95% CI, 1.2–6.9)) were significant predictors for ESBL-E colonisation. MRSA
colonization appeared higher in frail care areas (8/58 v 5/94, p = 0.07).
Conclusions: There was a relatively high prevalence of colonisation with MDROs, particularly ESBL-E, but low C.
difficile carriage, with implications for antibiotic prescribing and infection control practice.
Keywords: Residential care facility, Antibiotic resistance, C. difficile, Colonization, MRSA, ESBL, Infection control,
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Background
Antibiotic resistance (ABR) is a global public health crisis
undermining the ability to treat bacterial infections. ABR
is the inevitable consequence of antibiotic use in human
health and the environment and may correlate with anti-
biotic consumption [1, 2]. The increase in multidrug-
resistant organisms (MDRO) has necessitated a change in
empiric antibiotic prescribing practices, and patients with
healthcare-associated infections, including from residen-
tial care facilities (RCFs), are now often treated with
second-line broad-spectrum antibiotics [3]. It is therefore
critical to risk-stratify patients for infection with MDRO
to support optimal antibiotic prescribing.
Colonisation (defined as asymptomatic carriage) with
MDROs is a well-established risk factor for infection
with the same strain [4, 5], particularly in immunocom-
promised and elderly populations [6, 7]. RCFs are in-
creasingly recognized as reservoirs for MDROs [4, 8, 9]
and colonisation with MDR bacteria has been associated
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with outbreaks after referral of RCF residents to acute
care facilities [10]. Additionally, residents of RCFs in
high income countries have high rates of Clostridioides
difficile (previously Clostridium difficile) colonisation
[11] and are susceptible to C. difficile infection (CDI) be-
cause of advanced age and frequent antibiotic use [12].
ABR is common in South African referral hospitals.
Up to 70% of K. pneumoniae bloodstream isolates are
extended-spectrum beta-lactamase (ESBL) producing
strains [13], defined as being resistant to beta-lactam an-
tibiotics, including third-generation cephalosporins such
as cefotaxime, ceftriaxone, and ceftazidime. Almost a
quarter of Staphylococcus aureus bloodstream infections
at one tertiary academic centre were resistant to cloxa-
cillin (methicillin-resistant S. aureus, MRSA) [13]. There
are no published data on the prevalence of colonisation
with MDROs or C. difficile amongst residents of RCFs in
South Africa, but this is needed to guide recommenda-
tions for empiric antibiotic prescribing and infection
control practices in these facilities. We performed a
cross-sectional microbiological prevalence survey at
three RCFs in Cape Town, South Africa, to determine
the prevalence of colonization with ESBL-producing En-
terobacteriaceae (ESBL-E), MRSA and toxigenic C. diffi-
cile; and identify risk factors for colonization.
Methods
Study setting and population
There are approximately 30 RCFs in the Cape Town
metropolitan area. The majority of these institutions are
operated by a non-profit organisation, the Cape Penin-
sula Organisation for the Aged (CPOA), which operate
25 facilities with ~ 3000 residents. We selected three fa-
cilities for inclusion in a cross-sectional prevalence sur-
vey. Facility selection was based on the following
parameters: 1) a review of resident profiles (socioeco-
nomic status, ethnicity) to approximate a broadly repre-
sentative demographic sample of RCF residents; 2)
availability of frail care facilities, which was not offered
at all institutions; and 3) access to both public and pri-
vate hospitals at different levels of care.
A random list of residents was generated at each facil-
ity, stratified by independent living and frail care areas.
Frail care was defined as a specialised area in the RCF
where residents require 24-h nursing care or supervi-
sion. These residents generally require assistance with
activities of daily living (e.g. washing, dressing, eating),
mobilisation, and taking of medicines [14]. Residents
identified from the random lists were approached for
participation in the study. In addition to active recruit-
ment, information leaflets were distributed and formal
presentations were done at each facility to encourage
participation. Residents (or their legal representative
where appropriate) expressing interest in participating
were asked to provide written/telephonic informed con-
sent prior to enrolment.
Sources of data
Risk factors for colonisation with MDROs and C. difficile.
The following demographic and clinical data were col-
lected at a single study visit through interviews and
medical record reviews: presence of faecal/urinary incon-
tinence, presence indwelling medical device, hospital ex-
posure within last 6 months, systemic antibiotic
exposure within the last 3 months, current use of proton
pump inhibitors, functional and cognitive performance,
presence of any skin ulceration, medical comorbidities
(using the Charlson index), and any previous microbio-
logical results in last 6 months. These were selected be-
cause of documented and putative associations with
MDROs and C. difficile [4, 6, 9, 15–17]. Functional per-
formance was assessed using the Katz Index of Inde-
pendence in Activities of Daily Living (Katz ADL) which
evaluates ability to perform ADLs and plan selfcare [18].
Scores ≤2 indicate severe functional impairment, 3–5
mild-to-moderate impairment, and 6 indicates inde-
pendence. The presence of dementia was ascertained
from medical records and through clinical assessment by
the study doctor combined with simple screening tools
(3-word recall) and the assessment of the facility nursing
staff [19, 20]. All data were collected using standardised
case report forms.
Microbiological data
Skin swabs of nasal, axillary and inguinal areas were per-
formed to screen for carriage of MRSA. Stool was col-
lected from each participant to screen for colonisation
with ESBL-E and toxigenic C. difficile. All specimens
were processed at the National Health Laboratory Ser-
vices (NHLS) clinical microbiology laboratory at Groote
Schuur Hospital, Cape Town. Skin swabs and stool sam-
ples were plated onto chromogenic screening agar,
ChromID MRSA and ChromID ESBL agar plates (bio-
Mérieux, Marcy I’Etoile, France). After incubation, sug-
gestive colonies were identified and antibiotic
susceptibility testing was performed using the Vitek 2
System (bioMérieux), and interpreted with Clinical La-
boratory Standards Institute (CLSI) 2017 criteria. We
did not screen for vancomycin-resistant Enterococci due
to low prevalence in South African hospitals. Although
carbapenem-resistant Enterobacteriaceae were not spe-
cifically screened for, these are also detected on the
ChromID ESBL agar plates. An automated nucleic acid
amplification test, Xpert C. difficile (Cepheid, Sunnyvale,
CA, USA) was initially used to screen for toxigenic C.
difficile in stool samples. This was later changed to a
two-step algorithm where samples were screened with
the dual antigen (glutamate dehydrogenase (GDH) and
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toxins A and B) with a C. Diff Quik Chek Complete test
(TechLab, Blacksburg, VA, USA). C. difficile carriage
was defined by positivity of both GDH and toxin assays;
GDH-positive and toxin-negative samples reflexed to
Xpert C. difficile testing.
Analysis
The primary outcome measure was the proportion of
residents colonised with MDROs and toxigenic C. diffi-
cile. Assuming a combined population of ~ 420 residents
at the recruitment facilities, a sample size of 150 was
planned to detect an ESBL-E colonisation prevalence of
20% with 5% precision. Associations between MDRO
colonisation and participant characteristics were identi-
fied using the Wilcoxon rank sum test for continuous
variables and χ2 test for categorical variables. Logistic re-
gression was used to determine the risk factors associ-
ated with colonisation. Univariable analysis included the
following pre-specified variables, plus significant associa-
tions identified in the descriptive analysis: hospitalisation
and/or antibiotic exposure within the previous 3 or 6
months, non-ambulatory status, presence of pressure ul-
cers, and Charlson score. These variables were included in
a multivariable model to adjust for potential confounding,
using a backward stepwise selection strategy (P < 0.2). We
combined significant predictors and evaluated accuracy
for predicting MDRO colonisation by calculating the area
under the receiver operating characteristic curve
(AUROC). Analysis was performed in Stata (Version 14.2;
Stata Corp, College Station, Texas, USA).
Results
Characteristics of study population
The combined population size of the three selected
RCFs was 497, including 160 (32%) residents in frail
care. Between March 2017 and April 2018, 172 (35%)
residents were approached for participation: 18 declined
and a total of 154 participants enrolled (Fig. S1 in sup-
plementary material). The cohort included 59 (38%) resi-
dents from frail care and 95 from independent living
areas. Median age was 79 years (interquartile range
(IQR) 74–86) and 111 (72%) residents were female.
Thirty-seven (24%) participants were bed- or chair-
bound and the majority (n = 102, 67%) had Katz scores
≥5, indicating limited/no functional impairment. Forty-
five (29.2%) had a diagnosis of dementia; median Charl-
son score was 1 (IQR 0–2). Urinary incontinence was
present in 56 (36%) of participants and faecal incontin-
ence in 24 (16%). Median time in the residence at the
time of study participation was 41months (IQR 17–72).
Eighteen (12%) participants had been admitted to hos-
pital in the previous six months and 38 (25%) had re-
ceived systemic antibiotics in the previous three months.
Prevalence of colonisation with MDROs and C. difficile
Stool samples were obtained from 119 residents. ESBL-E
colonisation was detected in 27/119 (23%; 95% confi-
dence interval (CI), 16–31%), comprising the following
organisms: E. coli (17/27 isolates, 63%), K. pneumoniae
(5/27 isolates, 19%), E. cloacae (4/27 isolates, 15%), and
a single participant with mixed growth of E. cloacae and
E. coli. Additional resistance to ciprofloxacin was de-
tected in 19% (5/27), piperacillin-tazobactam in 11% (3/
27) and gentamicin in 30% (8/27) (Fig. 1). All isolates
were susceptible to carbapenems.
One hundred fifty-two sets of skin swabs were col-
lected. A set was defined as three single swabs used to
sample the nares, axillae and groin from an individual
participant. MRSA was recovered from 13/152 (9%; 95%
CI, 9–14%) individuals. The frequency of MRSA colon-
isation according to sampling site was: nasal 47%, groin
33% and axillae 20%. Four (3%, n = 117) participants had
evidence of concurrent MRSA and ESBL-E colonisation.
Two (1.7%, n = 119) stool samples from asymptomatic
residents were positive for C. difficile; both detected
using the GDH antigen and toxin assay (n = 81). The re-
mainder (n = 38) were tested using a nucleic acid ampli-
fication test with no positive results.
Factors associated with MDRO colonisation
A significantly higher proportion of participants colonised
with ESBL-E had urinary and/or faecal incontinence (59.3%
vs. 33.7% in those not colonised; P = 0.02) (Table 1). The
prevalence of ESBL-E amongst participants with incontin-
ence was 34% (16 cases, n = 47), and a 2.9-fold increased
odds (95% CI 1.2–6.9) of EBSL-E colonisation with any
form of incontinence. ESBL-E colonisation was also associ-
ated with lower Katz ADL scores; there was a 1.3-fold (95%
CI 1.0–1.6; P = 0.03) increased odds of colonisation for
every 1-point reduction in the Katz ADL. Incontinence
remained an independent predictor of ESBL-E colonisation
on multivariable analysis, adjusted odds ratio (OR) 3.2
(1.3–8.1) (Table 2). ESBL-E colonisation was present in
53.3% (8 cases, n = 15) of participants with a combination
of incontinence plus Katz score ≤ 2, significantly higher
compared to participants without either condition (13.8%; 9
cases, n = 65). However, the discriminatory value of this risk
factor combination was poor with AUROC 0.67 (95% CI
55–78). Colonized individuals were observed to have a
higher median Charlson score (2 v 1, p = 0.06). There were
no other associations between pre-specified risk factors and
colonisation with ESBL-E (Table 1).
As shown in Table 3, participants colonised with
MRSA had resided in their respective facilities for sig-
nificantly less time compared to those who were not
colonised with MRSA (20.9 vs 44.2 months; P = 0.04).
There was a numerically higher proportion of MRSA-
colonised individuals in frail care areas (61.5% vs. 36.0%
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in independent living areas; P = 0.07). The prevalence of
MRSA colonisation amongst those in frail care was
13.8% (8 cases, n = 58), a non-significant 2.8-fold (95%
CI, 0.9–9.2) increased odds of MRSA compared with
participants residing in independent living areas. Multi-
variable analysis was not performed for MRSA colonisa-
tion because of low case numbers.
Discussion
Determining the prevalence of colonisation with MDROs
and C. difficile amongst RCF residents is important to inform
empiric antibiotic selection and infection control practices.
In South Africa, guidelines for managing RCF residents with
infection are not based on local data, and this knowledge gap
formed the rationale for the present study. We found that
amongst 154 residents at three RCFs in Cape Town, the
prevalence of ESBL-E and MRSA colonisation was 23 and
8%, respectively. C. difficile carriage was uncommon, identi-
fied in only two participants. Urinary or faecal incontinence
and poor functional status were associated with ESBL-E car-
riage, and there was a trend towards increased risk of MRSA
colonisation amongst residents in frail care.
Fig. 1 Susceptibility of ESBL-E isolates to commonly-used antibiotics
Table 1 Associations with ESBL-E colonisation
Colonised (n = 27) Not colonised (n = 92) Prevalence ESBL-E (%) P-value
Facility
Facility 1 15 (55.6) 33 (35.9) 31.2 0.109
Facility 2 12 (44.4) 53 (57.6) 18.5
Facility 3 0 (0) 6 (6.5) 0
Time in facility, months 43.9 (22.9–65.2) 40.7 (14.3–73.6) NA 0.992
Frail care resident 12 (44.4) 26 (28.3) 31.6 0.113
Any incontinence 16 (59.3) 31 (33.7) 34.0 0.017
Hospital exposure in last 6 months 10 (37.0) 21 (22.8) 32.3 0.139
Systemic antibiotic exposure last 3 months 8 (29.6) 18 (20.0) 30.8 0.291
Previous positive culture from a clinical specimena 7 (36.8)b 20 (39.2)c 25.9 0.856
Bedbound or chair-bound 9 (33.3) 17 (18.5) 34.6 0.100
Katz score 6 (2–6) 6 (4–6) NA 0.048
Dementia 10 (37.0) 20 (21.7) 33.3 0.107
Charlson index score 2, (1, 2) 1, (1, 2) NA 0.058
Currently using PPI 8 (29.6) 19 (70.4) 19.6 0.090
Data are median (IQR) or n (percent). PPI, proton pump inhibitor
a. Includes microbiological evidence of S. aureus, Enterobacteriaceae, C. difficile
b.n = 19
c.n = 51
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There is a large amount of variability in published
MDRO prevalence amongst long-term care facility resi-
dents. Estimates of ESBL-E colonisation in European
series ranged between 4 and 64% [8, 9, 16, 21], similar to
reports from the US [4, 15]. The wide range in preva-
lence is likely due to heterogeneity in study population.
For example, inconsistent definitions of ‘long-term care
facility’ are applied, some of which encompass acute care
step down facilities expected to have higher prevalence
of MDROs compared with RCFs, where residents are
less sick and have less exposure to antibiotics [22–24].
ESBL-E colonisation was detected in 12% of residents
(n = 119) in 3 residential aged care facilities in Australia
[25]. Similar to our study the majority of residents were
highly mobile and no association between recent anti-
biotic use, length of stay, urinary catheterisation, pres-
ence of diarrhoea and ESBL-E colonisation was found.
The reported rates of C. difficile were also very low (1%),
as in our study. In Belfast, Ireland, very high rates of
ESBL-E colonisation (40%) were reported from 294 resi-
dents across 16 nursing homes; in contrast to our study,
residents generally had high exposure to systemic anti-
biotic therapy, which was a significant risk factor for col-
onisation with ESBL-E [26].
These observations support our hypothesis that the local
prevalence of colonisation in RCFs would be similar to that
in high income settings. This high prevalence of ESBL-E col-
onisation (23%), plus additional resistance to ciprofloxacin
(18%) amongst residents from RCFs in Cape Town suggests
risk of treatment failure with the use of third generation
cephalosporins and quinolones for common infection syn-
dromes such as urinary tract infection and pneumonia.
Our findings are consistent with others showing
Gram-negative bacteria to be the most prevalent multi-
Table 2 Univariable and multivariable analysis of risk factors associated with ESBL-E colonisation
Univariable Multivariable (n = 117)
Parameter Odds ratio (95% CI) P value Odds ratio (95% CI) P value
Any incontinence 2.9 (1.2–6.9) 0.019 3.2 (1.3–8.1) 0.013
Katz ADL 1.3 (1.0–1.6) 0.027
Systemic antibiotic exposure last 3 months 1.7 (0.6–4.5) 0.294
Hospital exposure in last 6 months 1.9 (0.8–4.9) 0.143 2.0 (0.8–5.5) 0. 154
Non-ambulatory 2.2 (0.8–5.7) 0.105
Charlson score 1.4 (0.9–2.2) 0.119
Katz ADL score, antibiotic exposure, non-ambulatory status, and Charlson score were dropped from the multivariable model due to P-value exceeding including
pre-defined inclusion threshold (P < 0.2). Presence of pressure ulcers was not included as a predictor due to insufficient data (n = 4)
Table 3 Associations with MRSA colonisation
Colonised (n = 13) Not colonised (n = 139) Prevalence of MRSA (%) P-value
Facility
Facility 1 6 (46.2) 55 (39.6) 9.8 0.167
Facility 2 5 (38.5) 78 (56.1) 6.0
Facility 3 2 (15.4) 6 (4.3) 25.0
Time in facility, months 20.9 (17.3–36.4) 44.2 (17.6–76.7) NA 0.042
Frail care resident 8 (61.5) 50 (36.0) 13.0 0.070
Any incontinence 5 (38.5) 57 (41.0) 8.1 0.858
Hospital exposure in last 6 months 2 (15.4) 39 (28.1) 4.9 0.325
Systemic antibiotic exposure last 3 months 3 (25.0) 35 (25.6) 7.9 0.967
Previous positive culture from a clinical specimena 4 (50)b 33 (40.2)c 10.8 0.592
Mobility status (bedbound/chair bound) 5 (38.5) 32 (23.0) 13.5 0.215
Katz score: median 5.5 (4–6) 6 (3–6) NA 0.766
Dementia 4 (30.8) 41 (29.5) 8.9 0.923
Charlson index score 1 (0–2) 1 (0–2) NA 0.848
Currently using PPI 3 (23.1) 10 (76.9) 8.1 0.701
Data are median (IQR) or n (percent). PPI Proton pump inhibitor
a. Includes microbiological evidence of S. aureus, Enterobacteriaceae, C. difficile
b. n = 8
c. n = 82
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resistant pathogens recovered from RCF residents. For
example, a cross-sectional study at a large LTCF in Bos-
ton found that 51% of sampled residents (n = 84) were
colonised with multi-drug resistant Gram-negative bac-
teria compared to MRSA in 28% and vancomycin-
resistant enterococci in 4% [4]. A longitudinal study con-
ducted at a LTCF in Northern Ireland demonstrated
similar results, with half of included residents (n = 64)
positive for ESBL-E and a quarter for MRSA [16].
Poor functional status (i.e. residents requiring assist-
ance with ADLs) and impaired mobility, with or without
dementia, have been identified as significant factors for
ESBL-E and MRSA colonisation [9]. In our study poor
functional status (i.e those with a low Katz ADL score)
and any form of incontinence were significantly associ-
ated with ESBL-E colonisation. The prevalence of ESBL-
E colonisation with the combination of incontinence and
Katz score ≤ 2 was high (53%), but had poor discrimin-
atory value. Similar observations have been reported
from high-income countries. In a study from Melbourne,
Australia, where 115 residents from 4 facilities were
screened, faecal incontinence and significant functional
dependence (low Katz ADL score) were also shown to
be major factors for colonisation with MDROs [27].
Similar predictors for MDR Gram-negative colonisation
were found in a LTCF cohort in Boston: faecal incontin-
ence, need for assistance with ADLs, advanced dementia
and residing in units where more intensive nursing care
was provided [4]. These factors may lead to higher levels
of staff contact which result in cross-transmission [10].
It has been suggested that intensified infection preven-
tion and control (IPC) measures, such as wearing of
gowns and gloves by healthcare workers [28] and en-
hanced hygiene practices should be implemented for res-
idents at high risk for MDRO colonisation [29].
Screening for ESBL-E and isolation of carriers outside of
outbreak settings is controversial, and more evidence is
required to understand the impact of this strategy to
prevent transmission [30].
A comparatively low prevalence of MRSA colonisation
(9%) was seen in our cohort, in contrast to studies in high
income settings where MRSA prevalence ranged between
16 and 50% in various LTCF populations [31]. This dis-
crepancy may be a consequence of circulating epidemic
MRSA strains in the United States [34], which has not
been the case in South Africa [35]. Shorter median time
spent in RCFs was associated with MRSA colonisation in
our study (20.9 versus 44.2months for those not colo-
nised). This may have been a chance finding due to low
case numbers, and is susceptible to confounding factors
which could not be adjusted for, such as visits to acute
care facilities, which increases risk of MRSA acquisition
[15], and differences in antibiotic therapy and IPC prac-
tices of attending physicians. There was a trend towards
higher MRSA colonisation amongst residents in frail care;
this has been observed in other settings and is possibly re-
lated to more frequent use of invasive medical devices,
chronic wounds, and antibiotic exposure in this popula-
tion [36].
CDI is endemic in RCFs in high income countries with
incidence rates of 2.3 cases/10,000 resident days re-
ported [37]. In contrast, only 2/119 (< 2%) samples were
positive for C. difficile in our study. Studies at a Cape
Town tertiary hospital found that 9–16% of acute diar-
rhoeal illnesses were associated with C. difficile infection,
and the annual incidence of hospital-acquired diarrhoea
was much lower compared to high income countries
[38, 39]. These observations reflect the wide prevalence
ranges for C. difficile which has a complex epidemiology
across different settings, influenced by strain type, infec-
tion control and prescribing practices [40–42]. Active
surveillance for carriers of toxigenic C. difficile has been
advocated in high burden settings [43], but our findings
suggest this may not be necessary in South African
RCFs.
Our study has several limitations. As a result of limited
resources we could not recruit residents from all RCFs
in Cape Town, and selected a subset on the basis of rep-
resentative demographics. Further limiting generalisabil-
ity, we were unable to include all residents from the
three participating facilities, and there were imbalances
in number of participants across the RCFs. Although we
generated randomised lists of residents at each facility,
there is inherent bias in the recruitment process, and
residents with MDRO colonisation may have been sys-
tematically excluded. We attempted to preferentially
enrol residents in frail care areas in order to capture the
highest risk group, but consent was more challenging in
this population, skewing the sample towards independ-
ent living and less functional impairment. Our power to
detect associations with MDRO colonisation was limited
by low prevalence of MRSA colonisation, and because
only 77% (119/154) of participants were willing to pro-
vide stool samples for ESBL-E screening. Although reli-
able systems were in place to collect clinical data,
antibiotic exposure may have been underestimated as
medications received during hospital admissions and
clinic/general practitioner visits were incompletely docu-
mented. Finally, data collection occurred over a pro-
longed period due to logistic limitations and this may
have influenced our results as colonisation prevalence is
known to change over time [44].
Conclusions
Notwithstanding these limitations, our survey demon-
strated a relatively high prevalence of colonisation with
MDROs, particularly ESBL-E, but low C. difficile carriage
amongst residents of RCFs in Cape Town, South Africa.
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This has important implications for practice, including
review of local antibiotic prescribing guidelines to ensure
appropriate initial therapy for RCF residents. Crucially,
IPC interventions such as improved healthcare worker
hand hygiene and barrier nursing, as well as antibiotic
stewardship, should be implemented, and possibly tar-
geted at higher risk residents, including those with in-
continence and lower functional status, to interrupt the
transmission of MDROs in RCFs.
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